z-logo
open-access-imgOpen Access
Correction: A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer
Author(s) -
Stephanie I. Kim,
Andy H. Szeto,
Katherine P. Morgan,
Blaine Brower,
Mary Dunn,
Amir H. Khandani,
Paul A. Godley,
Tracy L. Rose,
Ethan Basch,
Matthew I. Milowsky,
Young E. Whang,
Daniel J. Crona
Publication year - 2021
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0262326
Subject(s) - enzalutamide , abiraterone , prostate cancer , radium 223 , medicine , oncology , abiraterone acetate , cancer , androgen deprivation therapy , androgen receptor , bone metastasis

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here